1.42

1.43% 0.02

Telomir Pharmaceuticals Inc (TELO)

Overview News Price History Discussions Forecast

Telomir Pharmaceuticals Inc stock is traded at $1.42, with a volume of 193.52K. It is up +1.43% in the last 24 hours and up +11.81% over the past month. Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Previous Close:

$1.40

Open:

$1.42

24h Volume:

193.52K

Relative Volume:

0.13

Market Cap:

$48.82M

Revenue:

Net Income/Loss:

$-16.14M

P/E Ratio:

-2.6296

EPS:

-0.54

Net Cash Flow:

$-3.99M

1W Performance:

+5.19%

1M Performance:

+11.81%

6M Performance:

-19.32%

1Y Performance:

-71.43%

1-Day Range:

$1.3706

$1.42

1-Week Range:

$1.35

$1.45

52-Week Range:

$1.12

$5.40

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name

Telomir Pharmaceuticals Inc

Sector

Healthcare (1130)

Industry

Biotechnology (631)

Phone

786-396-6723

Address

100 SE 2ND ST, MIAMI

Employee

Twitter

Next Earnings Date

2025-12-03

Latest SEC Filings

TELO's Discussions on Twitter

Compare TELO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TELO Telomir Pharmaceuticals Inc	1.42	48.13M	0	-16.14M	-3.99M	-0.54
VRTX Vertex Pharmaceuticals Inc	462.99	116.51B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	783.71	82.52B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	400.69	52.67B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	849.95	52.08B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	177.42	37.70B	447.02M	-1.18B	-906.14M	-6.1812

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-21-25	Initiated	Rodman & Renshaw	Buy

Telomir Pharmaceuticals Inc Stock (TELO) Latest News

Dec 23, 2025

Telomir Pharmaceuticals Reports Favorable IND-Enabling GLP Safety Results for Telomir-1 Supporting First-in-Human Clinical Development - The State Journal-Register

Dec 23, 2025

Dec 22, 2025

Momentum Shift: What is the fair value of Telomir Pharmaceuticals Inc stock nowPortfolio Profit Report & AI Driven Stock Movement Reports - moha.gov.vn

Dec 22, 2025

Telomir Pharmaceuticals sets CEO incentive awards and salary adjustment - Investing.com

Dec 22, 2025

Dec 20, 2025

Chipmakers Recap: Is Telomir Pharmaceuticals Inc. stock positioned for digital transformationQuarterly Market Summary & Accurate Technical Buy Alerts - ulpravda.ru

Dec 20, 2025

How Telomir Pharmaceuticals Inc. stock reacts to inflationary pressuresWeekly Market Report & Consistent Income Trade Recommendations - Улправда

Dec 20, 2025

Is Telomir Pharmaceuticals Inc. stock positioned for digital transformationTrend Following Strategies & Free High Yield Investment Strategies - Bollywood Helpline

Dec 20, 2025

Dec 19, 2025

How institutional buying supports Telomir Pharmaceuticals Inc. stock2025 Sector Review & Safe Capital Growth Trade Ideas - Улправда

Dec 19, 2025